NINDS requests applications for ancillary studies in immunomodulation clinical trials. This announcement is made together with 3 other NIH components.
The initiative supports mechanistic studies in clinical trials of immunomodulatory interventions for immune system-mediated diseases, and preventative and therapeutic vaccines for non-HIV/AIDS infectious diseases. The goal is to include subjects and use samples from clinical trials for evaluating immunologic and other relevant parameters to study and define the underlying immunological mechanisms of intervention or vaccine, mechanisms of disease pathogenesis, biomarkers of disease activity and therapeutic effect, and mechanisms of human immunologic function.
Potential applicants should contact Dr. Annette Rothermel, Division of Allergy, Immunology, and Transplantation, National Institute of Allergy and Infectious Disease (NIAID), NIH; telephone: 301-496-7104; email: email@example.com. For more information visit http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-08-011.html.